- Immunohistochemistry for human telomerase reverse transcriptase catalytic subunit (hTERT): a study of 143 benign and malignant soft tissue and bone tumoursRajiv M Patel
Department of Pathology and Dermatology, The University of Michigan, Ann Arbor, MI 48109 5602, USA
Pathology 41:527-32. 2009..Only a small number of mesenchymal tumours have been previously evaluated for hTERT expression. We hypothesised that hTERT expression would be frequently present in sarcomas, but not in benign tumours...
- FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic toolRajiv M Patel
Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Am J Dermatopathol 33:140-3. 2011..When applied to suspicious superficial myxoid or fibromyxoid neoplasms, the FUS FISH probe in formalin-fixed paraffin-embedded tissue can be a useful ancillary technique for diagnosis of this uncommon and deceptively bland tumor...
- Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experienceMunir R Tanas
Department of Pathology, Cleveland Clinic, Ohio, USA
Arch Pathol Lab Med 134:1797-803. 2010..Mesenchymal neoplasms harbor characteristic translocations and amplification of gene regions amenable to evaluation by fluorescence in situ hybridization (FISH)...
- Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendixRish K Pai
Department of Pathology, Cleveland Clinic, Cleveland, OH 44195, USA
Hum Pathol 45:227-35. 2014..Our results indicate that serrated lesions of the appendix often harbor KRAS mutations rather than BRAF mutations and suggest that the serrated pathway in the appendix is likely different than in the colon and rectum. ..